Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib: Patient-focused outcome results from the randomised phase III REACH study (vol 81, pg 17, 2017)

著录项

• 来源
  《European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)》 |2018年第2018期|共2页
• 作者

  Chau Ian; Peck-Radosavljevic Markus; Borg Christophe; Malfertheiner Peter; Seitz Jean Francois; Park Joon Oh; Ryoo Baek-Yeol; Yen Chia-Jui; Kudo Masatoshi; Poon Ronnie; Pastorelli Davide; Blanc Jean-Frederic; Chung Hyun Cheol; Baron Ari D.; Okusaka Takuji; Bowman L.; Cui Zhanglin Lin; Girvan Allicia C.; Abada Paolo B.; Yang Ling; Zhu Andrew X.;

  展开▼
• 作者单位

  Royal Marsden Hosp London England;

  Allgemeines Krankenhaus Wien Vienna Austria;

  Hosp Jean Minjoz Besancon France;

  Univ Klinikum Magdeburg Magdeburg Germany;

  Aix Marseille Univ Hop La Timone Marseille France;

  Sungkyunkwan Univ Sch Med Samsung Med Ctr Seoul South Korea;

  Asan Med Ctr Seoul South Korea;

  Natl Cheng Kung Univ Hosp Tainan Taiwan;

  Kinki Univ Sch Med Osaka Japan;

  Univ Hong Kong Hong Kong Hong Kong Peoples R China;

  Ist Oncol Veneto IRCCS Padua Italy;

  CHU Bordeaux Hepatogastroenterol &

  Digest Oncol Unit Ctr Medicochirurg Magellan Bordeaux France;

  Yonsei Univ Hlth Syst Yonsei Canc Ctr Seoul South Korea;

  Sutter Hlth Calif Pacific Med Ctr San Francisco CA USA;

  Natl Canc Ctr Tokyo Japan;

  Eli Lilly &

  Co Indianapolis IN 46285 USA;

  Eli Lilly &

  Co Indianapolis IN 46285 USA;

  Eli Lilly &

  Co Indianapolis IN 46285 USA;

  Eli Lilly &

  Co Indianapolis IN 46285 USA;

  Eli Lilly &

  Co Bridgewater NJ USA;

  Harvard Med Sch Massachusetts Gen Hosp Ctr Canc Boston MA USA;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 肿瘤学;
• 关键词